HOUSE DOCKET, NO. 3172        FILED ON: 1/20/2023

HOUSE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No. 963

The Commonwealth of Massachusetts

_________________

PRESENTED BY:

Peter Capano

_________________

To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
Court assembled:

The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:

An Act relative to costs for treatment and management of diabetes.

_______________

PETITION OF:

HOUSE DOCKET, NO. 3172        FILED ON: 1/20/2023

HOUSE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No. 963

[SIMILAR MATTER FILED IN PREVIOUS SESSION
SEE HOUSE, NO. 1055 OF 2021-2022.]

The Commonwealth of Massachusetts

_______________

In the One Hundred and Ninety-Third General Court
(2023-2024)

_______________

An Act relative to costs for treatment and management of diabetes.

Whereas, The deferred operation of this act would tend to defeat its purpose, which is to establish forthwith limits on out-of-pocket costs for the treatment of diabetes, therefore it is hereby declared to be an emergency law, necessary for the immediate preservation of the public convenience.
 

Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority of the same, as follows:
 

SECTION 1. Section 17G of chapter 32A of the General Laws, as appearing in the 2018 Official Edition, is hereby amended by inserting after the first sentence the following sentence:-

The deductible, copayment or coinsurance or other cost-sharing requirement shall not exceed: (1) $25 for a 30-day supply of insulin; (2) $50 for a 30-day supply of prescribed oral diabetes medications that influence blood sugar levels; and (3) $100 for all other items described in this section.

SECTION 2. Section 10C of chapter 118E of the General Laws, as appearing in the 2018 Official Edition, is hereby amended by inserting after the first sentence the following sentence:-

The deductible, copayment or coinsurance or other cost-sharing requirement shall not exceed: (1) $25 for a 30-day supply of insulin; (2) $50 for a 30-day supply of prescribed oral diabetes medications that influence blood sugar levels; and (3) $100 for all other items described in this section.

SECTION 3. Section 47N of chapter 175 of the General Laws, as appearing in the 2018 Official Edition, is hereby amended by inserting after the first sentence the following sentence:-

The deductible, copayment or coinsurance or other cost-sharing requirement shall not exceed: (1) $25 for a 30-day supply of insulin; (2) $50 for a 30-day supply of prescribed oral diabetes medications that influence blood sugar levels; and (3) $100 for all other items described in this section.

SECTION 4. Section 8P of chapter 176A of the General Laws, as appearing in the 2018 Official Edition, is hereby amended by inserting after the first sentence the following sentence:-

The deductible, copayment or coinsurance or other cost-sharing requirement shall not exceed: (1) $25 for a 30-day supply of insulin; (2) $50 for a 30-day supply of prescribed oral diabetes medications that influence blood sugar levels; and (3) $100 for all other items described in this section.

SECTION 5. Section 4S of chapter 176B of the General Laws, as appearing in the 2018 Official Edition, is hereby amended by inserting after the first sentence the following sentence:-

The deductible, copayment or coinsurance or other cost-sharing requirement shall not exceed: (1) $25 for a 30-day supply of insulin; (2) $50 for a 30-day supply of prescribed oral diabetes medications that influence blood sugar levels; and (3) $100 for all other items described in this section.

SECTION 6. Section 4H of chapter 176G of the General Laws, as appearing in the 2018 Official Edition, is hereby amended by inserting after the first sentence the following sentence:-

The deductible, copayment or coinsurance or other cost-sharing requirement shall not exceed: (1) $25 for a 30-day supply of insulin; (2) $50 for a 30-day supply of prescribed oral diabetes medications that influence blood sugar levels; and (3) $100 for all other items described in this section.